Menopausal symptoms such as hot flushes and night sweats can be very disrupting. While hormone replacement therapy is an effective therapy, concerns about side effects and breast cancer risk have stimulated interest into alternative therapies such as phytoe-strogens. These are oestrogen-like compounds made by plants. Two major sources of phytoestrogens are soy and red clover. Data on randomised controlled trials of red clover for the control of menopausal symptoms are presented. The conflicting data are encouraging and suggest that phytoestrogens are a treatment modality that needs pursuing.
ChlebowskiRT, HendrixSL, LangerRD, Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women's Health Initiative randomized trial. JAMA2003; 289: 3243–253.
2.
Million Women Study Collaborators.Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet2003; 362: 419–427.
3.
AdlercreutzH, MazurW.Phyto-oestrogens and Western diseases. Ann Med1997; 29: 95–120.
4.
AdlercreutzW.Phyto-oestrogens and cancer. Lancet Oncol2002; 3: 364–373.
5.
Consensus Opinion.The role of isoflavones in menopausal health: consensus opinion of the North American Menopause Society. Menopause2000; 7: 215–229.
6.
ErnstE.Herbalism and the menopause. J Br Menopause Soc2002; 8: 72–74.
7.
KnightDC, HowesJB, EdenJA.The effect of PromensilTM, an isoflavones extract, on menopausal symptoms. Climacteric1999; 2: 79–84.
8.
BaberRJ, TemplemanC, MortonT, Randomized placebo-controlled trial of an isoflavones supplement and menopausal symptoms in women. Climacteric1999; 2: 85–92.
9.
JeriAR.The use of an isoflavones supplement to relieve hot flushes. The Female Patient2002; 27: 35–37.
10.
Van de WeijerPHM, BarentsenR.Isoflavones from red clover (Promensil®) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas2002; 42: 187–193
11.
TiceJA, EttingerB, EnsrudK, Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA2003; 290: 207–214.
